NCT00596895View on ClinicalTrials.gov

Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Biochemical Recurrent Prostate Cancer
Interventions
DIETARY_SUPPLEMENT

Isoflavone

Ingested 47 mg of isoflavone in three 8 oz servings per day

Trial Locations (1)

32209

University of Florida Shands, Jacksonville

All Listed Sponsors
lead

University of Florida

OTHER

NCT00596895 - Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer | Biotech Hunter | Biotech Hunter